Business / Finance

RSS

EMA CHMP recommends approval for BioMarin's Novato manufacturing facility expansion

BioMarin Pharmaceutical Inc. announced today that the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended approval for the company's manufacturing facility expansion in Novato, CA.

19 Dec 2011

Rotech Healthcare acquires three home medical entities

Rotech Healthcare Inc., one of the largest providers of home medical equipment and related products and services, announced today its acquisition of three home medical entities.

19 Dec 2011

Delaware Court upholds original ruling in favor of PharmAthene

PharmAthene, Inc. today announced that the Delaware Court of Chancery has denied SIGA Technologies' motion for reargument filed on October 4, 2011, upholding the Court's original September 22, 2011 decision awarding PharmAthene 50% of the net profits over ten years from all sales of SIGA's smallpox antiviral therapeutic, ST-246, and related products, after SIGA receives the first $40 million in net profits.

19 Dec 2011

HA fillers will see highest growth among facial injectable products in 2013 rebound

According to Millennium Research Group, the global authority on medical technology market intelligence, poor economic conditions will limit growth of the European facial injectables market in 2011 and 2012 down to 2.5 percent per year, but the market will rebound strongly in 2013 and onward, reaching a rate of nearly 12 percent by 2016, for a total market of $420 million.

19 Dec 2011

Newgen acquires novel oncology development programs from Kanion

NewGen Therapeutics, Inc. today announced the acquisition of three novel oncology development programs from Kanion USA, Inc. and Kanion Pharmaceutical Co., Ltd..

19 Dec 2011

American Anesthesiology acquires Burlington Anesthesia Associates

American Anesthesiology, a division of MEDNAX, Inc., today announced the acquisition of Burlington Anesthesia Associates, a physician group practice that provides anesthesia services in Mt. Holly, NJ.

19 Dec 2011

Zimmer board approves quarterly cash dividend and new share repurchase program

Zimmer Holdings, Inc., a global leader in musculoskeletal care, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the first quarter of 2012.

19 Dec 2011

Patheon fourth quarter revenues increase to $181.6 million

Patheon Inc., a leading provider of contract development and manufacturing services to the global pharmaceutical industry, announced today full year and fourth quarter results.

19 Dec 2011

DDC acquires Orchid Cellmark's government paternity business

DDC (DNA Diagnostics Center), one of the largest DNA testing companies in the world, announced today the acquisition of Orchid Cellmark, Inc.'s government paternity business.

19 Dec 2011

Pfizer enters Prevenar 13 supply agreement to protect children from pneumococcal disease

Pfizer Inc. today announced it has entered into a second supply agreement which will broaden and extend the duration of the Company's commitment to help protect millions of infants and young children in the developing world from pneumococcal disease - the leading cause of vaccine-preventable death in young children.

17 Dec 2011

Angeion fourth quarter revenues increase 22% to $8.4 million

Angeion Corporation today reported financial results for its fourth quarter and fiscal year ended October 31, 2011.

16 Dec 2011

Ensign declares quarterly cash dividend of $0.06 per share

The Ensign Group, Inc., the parent company of the Ensign group of skilled nursing, rehabilitative care services and assisted living companies, today announced that its Board of Directors has declared a quarterly cash dividend of $0.06 per share of Ensign common stock, payable on or before January 31, 2012 to shareholders of record as of December 31, 2011.

16 Dec 2011

FUJIFILM to acquire SonoSite

FUJIFILM Holdings Corporation, a diversified technology company that operates in healthcare, highly functional materials, and document solutions, announced today that it has entered into a definitive agreement with SonoSite, Inc., a pioneer and leader in bedside and point-of-care ultrasound technology, pursuant to which Fujifilm will acquire SonoSite for approximately $995 million.

15 Dec 2011

Sartorius acquires liquid handling business from Biohit Oyj

Yesterday Sartorius, a leading international process and laboratory technology provider, successfully completed its acquisition of the liquid handling business of the Finnish laboratory supplier Biohit Oyj.

From Sartorius 15 Dec 2011

IASIS Healthcare fourth quarter net revenue increases 13.8% to $716.8 million

IASIS Healthcare LLC today announced financial and operating results for the fiscal fourth quarter and year ended September 30, 2011.

14 Dec 2011

Baxter to acquire Synovis

Baxter International Inc. and Synovis Life Technologies, Inc. today announced a definitive agreement for Baxter to acquire Synovis, a leading provider of biological and mechanical products for soft tissue repair used in a variety of surgical procedures.

From Baxter International Inc. 14 Dec 2011

ImmusanT secures $20M in Series A financing

ImmusanT, Inc. announced today it has raised $20 million in Series A financing from Vatera Healthcare Partners LLC to advance development of the biotechnology company's immunotherapeutic vaccine Nexvax2, companion diagnostic and monitoring tool for celiac disease.

14 Dec 2011

Quintiles launches Kun Tuo to service unique needs of biopharma companies in China

Further deepening its commitment to China, Quintiles today announced the launch of Kun Tuo, a local contract research organization (CRO) built to service the unique needs of the Chinese biopharmaceutical industry and multinational biopharma companies operating in China.

13 Dec 2011

Supply chain map could help improve access to anti-malarial drugs

The problems of archaic logistics infrastructure, inefficient distribution channels and disruptive black markets must all be addressed urgently if Africa is to cope with the growing problem of malaria, according to a study published in the International Journal of Logistics Systems and Management.

13 Dec 2011

PDL corrects earlier-announced adjusted conversion rates for two Notes

PDL BioPharma, Inc. (PDL) today corrected its earlier-announced adjusted conversion rate for its: 2.875% Convertible Senior Notes due February 15, 2015 (February 2015 Notes), to 155.396 shares of common stock per $1,000 principal amount, reflecting a conversion price of approximately $6.44 per share, effective December 9, 2011.

12 Dec 2011